MaxCyte
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of MaxCyte generated cash of -$21,686,000, which is less than the previous year. Cash used in financing activities reached the amount of $2,143,000 last year. Net change in cash is therefore $35,441,000.
Cash Flow
| 2014 | -1.92M | -147K | 4.71M |
|---|---|---|---|
| 2015 | -180.5K | -94.5K | -722.1K |
| 2016 | -2.33M | -218.8K | 11.86M |
| 2017 | -9.67M | -609.7K | 23.90M |
| 2018 | -10.48M | -3.83M | 226.8K |
| 2019 | -8.80M | 454.5K | 12.31M |
| 2020 | -8.78M | -16.57M | 28.90M |
| 2021 | -10.67M | -195.01M | 234.72M |
| 2022 | -14.78M | -24.82M | 2.88M |
| 2023 | -21.68M | 54.98M | 2.14M |
MXCT Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 11.06M | 47.78M | 18.75M | 15.21M | 11.24M | 25.34M | 11.72M | 2.41M | 3.40M | 764.9K |
Operating activities | ||||||||||
Net income | -37.92M | -23.57M | -19.08M | -11.81M | -12.89M | -8.86M | -9.91M | -3.34M | -1.44M | -1.83M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 4.17M | 2.69M | 1.42M | 1.04M | 613.5K | 344K | 142.9K | 105.7K | 93.3K | 92K |
Stock-based compensation expense | 13.97M | 11.75M | 7.95M | 2.47M | 1.75M | 0 | 514.5K | 154.1K | 1.2K | 95.6K |
| Deferred income tax benefit | 13.97M | 11.75M | 7.95M | 2.47M | 1.75M | 0 | 514.5K | 154.1K | 1.2K | 95.6K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 7.13M | -6.69M | -1.70M | -1.81M | 1.59M | -1.94M | -784.9K | -959.4K | -49.4K | -634.8K |
Inventories | 697K | -3.49M | -1.40M | -890.6K | -1.89M | -1.28M | -174.9K | -248.7K | -144.8K | -214.3K |
Accounts payable | 3.25M | -149.7K | 2.09M | 391K | 1.04M | -689.1K | 849K | 1.23M | 618.2K | -68.4K |
Cash generated by operating activities | -21.68M | -14.78M | -10.67M | -8.78M | -8.80M | -10.48M | -9.67M | -2.33M | -180.5K | -1.92M |
Investing activities | ||||||||||
Purchases Of Investments | -255.09M | -290.94M | -268.68M | -22.50M | -7.42M | -12.67M | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -3.7M | -18.47M | -3.83M | -2.07M | -1.27M | -709.7K | -609.7K | -218.8K | -94.5K | -147K |
Acquisitions Net | 0 | 6.34M | 4.6K | 14.50M | -1.72M | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 54.98M | -24.82M | -195.01M | -16.57M | 454.5K | -3.83M | -609.7K | -218.8K | -94.5K | -147K |
Financing activities | ||||||||||
Common Stock Issued | 269K | 0 | 236.07M | 28.56M | 12.33M | 230K | 23.89M | 11.93M | 9K | 72.5K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | -4.98M | -1.50M | -152.2K | -286.9K | -14.3K | -16.6K | -54.4K | -1.80M |
Cash used in financing activities | 2.14M | 2.88M | 234.72M | 28.90M | 12.31M | 226.8K | 23.90M | 11.86M | -722.1K | 4.71M |
Net Change In Cash | 35.44M | -36.71M | 29.02M | 3.54M | 3.96M | -14.09M | 13.61M | 9.31M | -997.1K | 2.64M |
Cash at end of period | 46.50M | 11.06M | 47.78M | 18.75M | 15.21M | 11.24M | 25.34M | 11.72M | 2.41M | 3.40M |
| Data source | Data source | Data source |